Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2400 (LINC02400) is a human gene that encodes a long intergenic non-coding RNA (lincRNA), meaning it produces an RNA molecule greater than 200 nucleotides in length which does not encode a protein[1][5][3]. LINC02400 belongs to the lncRNA/lincRNA class, which broadly function in gene expression regulation, chromatin remodeling, and maintenance of cellular transcriptional states, but to date, there is no published evidence for its specific biological function, disease role, interaction with drugs, or clinical biomarker utility[1][3][5]. Key context: - LINC02400 should not be confused with numerically similar lincRNAs such as LINC00665, which have known functions in cancer[2]. - Unlike some lincRNAs, LINC02400 has not yet been linked to specific cellular pathways, disease states, or drug response[1][5]. - The gene is categorized as a non-protein coding gene and is referenced in genomic databases, but without characterized roles in disease or therapy[1][5].
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2400 (LINC02400).